Alvotech - Ordinary Shares (NQ:ALVO)
All News about Alvotech - Ordinary Shares

Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022
From Alvotech
Via GlobeNewswire



Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
November 14, 2022
From Alvotech
Via GlobeNewswire



Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
October 26, 2022
From Alvotech
Via GlobeNewswire



Alvotech Appoints Sarah Tanksley as Chief Quality Officer
October 11, 2022
From Alvotech
Via GlobeNewswire



Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Via Benzinga









Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.